Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Ophthalmological Medicine
Volume 2011, Article ID 576521, 3 pages
http://dx.doi.org/10.1155/2011/576521
Case Report

Limbitis Secondary to Autologous Serum Eye Drops in a Patient with Atopic Keratoconjunctivitis

Illinois Eye and Ear Infirmary, University of Illinois at Chicago, 1855 West Taylor Street, Chicago, IL 60612, USA

Received 3 November 2011; Accepted 1 December 2011

Academic Editors: S.-J. Chen, S. Machida, and N. Rosa

Copyright © 2011 Jeffrey David Welder et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. A. Noble, R. S. K. Loh, S. MacLennan et al., “Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease,” British Journal of Ophthalmology, vol. 88, no. 5, pp. 647–652, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Tsubota, E. Goto, S. Shimmura, and J. Shimazaki, “Treatment of persistent corneal epithelial defect by autologous serum application,” Ophthalmology, vol. 106, no. 10, pp. 1984–1989, 1999. View at Google Scholar · View at Scopus
  3. G. Geerling, S. MacLennan, and D. Hartwig, “Autologous serum eye drops for ocular surface disorders,” British Journal of Ophthalmology, vol. 88, no. 11, pp. 1467–1474, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. J. S. López-García, I. García-Lozano, L. Rivas, and J. Martínez-Garchitorena, “Use of autologous serum in ophthalmic practice,” Archivos de la Sociedad Espanola de Oftalmologia, vol. 82, no. 1, pp. 9–20, 2007. View at Google Scholar
  5. Y. Ohashi, M. Motokura, Y. Kinoshita et al., “Presence of epidermal growth factor in human tears,” Investigative Ophthalmology and Visual Science, vol. 30, no. 8, pp. 1879–1882, 1989. View at Google Scholar · View at Scopus
  6. A. Gupta, D. Monroy, Z. Ji, K. Yoshino, A. Huang, and S. C. Pflugfelder, “Transforming growth factor beta-1 and beta-2 in human tear fluid,” Current Eye Research, vol. 15, no. 6, pp. 605–614, 1996. View at Google Scholar · View at Scopus
  7. K. Tsubota, E. Goto, H. Fujita et al., “Treatment of dry eye by autologous serum application in Sjogren's syndrome,” British Journal of Ophthalmology, vol. 83, no. 4, pp. 390–395, 1999. View at Google Scholar · View at Scopus
  8. Y. Matsumoto, M. Dogru, E. Goto et al., “Autologous serum application in the treatment of neurotrophic keratopathy,” Ophthalmology, vol. 111, no. 6, pp. 1115–1120, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. Y. Ogawa, S. Okamoto, M. Yamada et al., “Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease,” Bone Marrow Transplantation, vol. 31, no. 7, pp. 579–583, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. E. Goto, S. Shimmura, J. Shimazaki, and K. Tsubota, “Treatment of superior limbic keratoconjunctivitis by application of autologous serum,” Cornea, vol. 20, no. 8, pp. 807–810, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Noda-Tsuruya, N. Asano-Kato, I. Toda, and K. Tsubota, “Autologous serum eye drops for dry eye after LASIK,” Journal of Refractive Surgery, vol. 22, no. 1, pp. 61–66, 2006. View at Google Scholar · View at Scopus
  12. S. C. Leite, R. S. de Castro, M. Alves et al., “Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation,” Bone Marrow Transplantation, vol. 38, no. 3, pp. 223–227, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. P. J. McDonnell, D. J. Schanzlin, and N. A. Rao, “Immunoglobulin deposition in the cornea after application of autologous serum,” Archives of Ophthalmology, vol. 106, no. 10, pp. 1423–1425, 1988. View at Google Scholar · View at Scopus
  14. A. C. Poon, G. Geerling, J. K. G. Dart, G. E. Fraenkel, and J. T. Daniels, “Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies,” British Journal of Ophthalmology, vol. 85, no. 10, pp. 1188–1197, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Stumpf, N. Luqmani, P. Sumich, S. Cook, and D. Tole, “Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis,” Cornea, vol. 25, no. 10, pp. 1147–1149, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. L. Bielory, “Ocular allergy guidelines: a practical treatment algorithm,” Drugs, vol. 62, no. 11, pp. 1611–1634, 2002. View at Google Scholar · View at Scopus